*Atlanta Urogynecology Associates, Alpharetta, GA; †Cleveland Clinic Florida, Weston, FL; ‡Dupont Center for Urology and Urogynecology, Bethesda, MD; §Good Samaritan Hospital, Cincinnati, OH; ¶Center for Urological Control, Nashville, TN; ∥Brigham & Women's Hospital, Boston, MA; **North Shore University Hospital, Great Neck, NY; ††Urology Associates of Norwalk, Norwalk, CT; and ‡‡Cleveland Clinic Foundation, Cleveland, OH
Disclosure – Grant/Research Support: American Medical Systems (AMS): R.D. Moore, G.W. Davila, M.C. Dupont, M. Karram, L.D. Knoll, N. Kohli, L.R. Lind, J. Miklos, S.R. Serels, M.D. Walters, H.A. Winkler; Bard Urology: R.D. Moore, J Miklos; Consultant: AMS: R.D. Moore, M.C. Dupont, L.D. Knoll, N. Kohli, S. Serels, M.D. Walters; Bard Urology: J. Miklos, R.D. Moore, N. Kohli; Speaker's Bureau: Pfizer: R.D. Moore, J. Miklos, N. Kohli; Yamanouchi: R.D. Moore, J. Miklos; Odyssey: R.D. Moore, J. Miklos; Ortho McNeil: R.D. Moore, J. Miklos; Other: Medical Advisory Board—AMS: G.W. Davila.